Triethylamine → HCID 50898356, compound
Reaction equation
[F:1][C:2]1[C:3]([N:9]=[CH:10][N:11]([CH3:13])[CH3:12])=[N:4][C:5]([OH:8])=[N:6][CH:7]=1.C(N(CC)CC)C.Cl[C:22]([O:24][CH2:25][C:26]([CH3:29])([CH3:28])[CH3:27])=[O:23]>ClCCl>[CH3:27][C:26]([CH3:29])([CH3:28])[CH2:25][O:24][C:22]([N:6]1[CH:7]=[C:2]([F:1])[C:3]([N:9]=[CH:10][N:11]([CH3:13])[CH3:12])=[N:4][C:5]1=[O:8])=[O:23]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To an 8 mL screw-cap vial was added dichloromethane (CH2Cl2; 3 milliliters (mL)), N′-(5-fluoro-2-hydroxy-pyrimidin-4-yl)-N,N-dimethylformamidine (100 milligrams (mg), 0.54 millimole (mmol)), triethylamine (Et3N; 120 mg, 1.18 mmol), and 2,2-dimethylpropyl chloroformate (90 mg, 0.60 mmol). After shaking for 1.5 hours (h) at room temperature, the mixture was partitioned between ethyl acetate (EtOAc) and water (H2O). The organic phase was dried over magnesium sulfate (MgSO4), filtered, and evaporated. The crude material was purified by reverse phase chromatography to yield 4-(dimethylamino-methyleneamino)-5-fluoro-2-oxo-2H-pyrimidine-1-carboxylic acid 2,2-dimethyl-propyl ester as a white solid (33 mg, 20%): mp 162-164° C.; 1H NMR (300 MHz, CDCl3) δ 8.77 (s, 1H), 7.93 (d, J=6.6 Hz, 1H), 4.08 (s, 2H), 3.27 (s, 3H), 3.20 (s, 3H), 1.05 (s, 9H); ESIMS m/z 299 ([M+H]+).
Workup
- customTo an 8 mL screw-cap vial
- customthe mixture was partitioned between ethyl acetate (EtOAc) and water (H2O)
- dry with materialThe organic phase was dried over magnesium sulfate (MgSO4)
- filtrationfiltered
- customevaporated
- customThe crude material was purified by reverse phase chromatography
Sources & evidence
- ORD record
- ord-dc326d962ec74853a71e4125c8cfacfb
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08318758B2
Reaction notes
Loading…